EpCAM-based methods, therefore, fail to efficiently capture mesenchymal cells, leading to the selective isolation of CTC phenotypes that may not be representative of most cells being shed from a tumor that have the ability to establish themselves and grow at a distal site. This evidence concerns the gene EPCAM and neoplasm.